Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

Kazuaki Matsumoto; Yoshio Takesue; Norio Ohmagari; Takahiro Mochizuki; Hiroshige Mikamo; Masafumi Seki; Shunji Takakura; Issei Tokimatsu; Yoshiko Takahashi; Kei Kasahara; Kenji Okada; Masahiro Igarashi; Masahiro Kobayashi; Yukihiro Hamada; Masao Kimura; Yoshifumi Nishi; Yusuke Tanigawara; Toshimi Kimura

doi:10.1007/s10156-013-0599-4

Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

Kazuaki Matsumoto, Yoshio Takesue, Norio Ohmagari, Takahiro Mochizuki, Hiroshige Mikamo, Masafumi Seki, Shunji Takakura, Issei Tokimatsu, Yoshiko Takahashi, Kei Kasahara, Kenji Okada, Masahiro Igarashi, Masahiro Kobayashi, Yukihiro Hamada, Masao Kimura, Yoshifumi Nishi, Yusuke Tanigawara, Toshimi Kimura

研究成果: Article › 査読

142 被引用数 (Scopus)

本文言語	English
ページ（範囲）	365-380
ページ数	16
ジャーナル	Journal of Infection and Chemotherapy
巻	19
号	3
DOI	https://doi.org/10.1007/s10156-013-0599-4
出版ステータス	Published - 2013 6月
外部発表	はい

ASJC Scopus subject areas

微生物学（医療）
感染症
薬理学（医学）

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1007/s10156-013-0599-4

他のファイルとリンク

引用スタイル

Matsumoto, K., Takesue, Y., Ohmagari, N., Mochizuki, T., Mikamo, H., Seki, M., Takakura, S., Tokimatsu, I., Takahashi, Y., Kasahara, K., Okada, K., Igarashi, M., Kobayashi, M., Hamada, Y., Kimura, M., Nishi, Y., Tanigawara, Y., & Kimura, T. (2013). Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Journal of Infection and Chemotherapy, 19(3), 365-380. https://doi.org/10.1007/s10156-013-0599-4

Matsumoto, K, Takesue, Y, Ohmagari, N, Mochizuki, T, Mikamo, H, Seki, M, Takakura, S, Tokimatsu, I, Takahashi, Y, Kasahara, K, Okada, K, Igarashi, M, Kobayashi, M, Hamada, Y, Kimura, M, Nishi, Y, Tanigawara, Y & Kimura, T 2013, 'Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring', Journal of Infection and Chemotherapy, vol. 19, no. 3, pp. 365-380. https://doi.org/10.1007/s10156-013-0599-4

@article{48df956b4fac45899233d4242fb96179,

title = "Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring",

keywords = "Guideline, MRSA, Therapeutic drug monitoring, Vancomycin",

author = "Kazuaki Matsumoto and Yoshio Takesue and Norio Ohmagari and Takahiro Mochizuki and Hiroshige Mikamo and Masafumi Seki and Shunji Takakura and Issei Tokimatsu and Yoshiko Takahashi and Kei Kasahara and Kenji Okada and Masahiro Igarashi and Masahiro Kobayashi and Yukihiro Hamada and Masao Kimura and Yoshifumi Nishi and Yusuke Tanigawara and Toshimi Kimura",

note = "Funding Information: Conflict of interest Yoshio Takesue has received a speaker{\textquoteright}s honorarium from Pfizer Japan Inc., Astellas Pharma, Shionogi & Co., Ltd., MSD KK, Taisho Toyama Pharmaceutical Co., Ltd., and Dai-nippon Sumitomo Pharma. Yoshio Takesue has received Grant support from Pfizer Japan Inc., Astellas Pharma, Shionogi & Co., Ltd., MSD KK, Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, and Dainippon Sumitomo Pharma. Norio Ohmagari has received speaker{\textquoteright}s honorarium from Pfizer Japan Inc., Shionogi & Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd. Masafumi Seki has received a speaker{\textquoteright}s honorarium from Pham. Corporations as follows: Astellas Inc., MSD Inc., Pfizer Japan Inc., Shionogi Inc., and Taisho Toyama Inc. Shunji Takakura has received speaker{\textquoteright}s honorarium from Pfizer Japan Inc., Astellas Pharma Inc. Yusuke Tanigawara is a consultant to Meiji Seika Pharma Co., Ltd. Toshimi Kimura has received a speaker{\textquoteright}s honorarium from Meiji Seika Pharma.",

year = "2013",

month = jun,

doi = "10.1007/s10156-013-0599-4",

language = "English",

volume = "19",

pages = "365--380",

journal = "Journal of Infection and Chemotherapy",

issn = "1341-321X",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Practice guidelines for therapeutic drug monitoring of vancomycin

T2 - A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

AU - Matsumoto, Kazuaki

AU - Takesue, Yoshio

AU - Ohmagari, Norio

AU - Mochizuki, Takahiro

AU - Mikamo, Hiroshige

AU - Seki, Masafumi

AU - Takakura, Shunji

AU - Tokimatsu, Issei

AU - Takahashi, Yoshiko

AU - Kasahara, Kei

AU - Okada, Kenji

AU - Igarashi, Masahiro

AU - Kobayashi, Masahiro

AU - Hamada, Yukihiro

AU - Kimura, Masao

AU - Nishi, Yoshifumi

AU - Tanigawara, Yusuke

AU - Kimura, Toshimi

N1 - Funding Information: Conflict of interest Yoshio Takesue has received a speaker’s honorarium from Pfizer Japan Inc., Astellas Pharma, Shionogi & Co., Ltd., MSD KK, Taisho Toyama Pharmaceutical Co., Ltd., and Dai-nippon Sumitomo Pharma. Yoshio Takesue has received Grant support from Pfizer Japan Inc., Astellas Pharma, Shionogi & Co., Ltd., MSD KK, Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, and Dainippon Sumitomo Pharma. Norio Ohmagari has received speaker’s honorarium from Pfizer Japan Inc., Shionogi & Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd. Masafumi Seki has received a speaker’s honorarium from Pham. Corporations as follows: Astellas Inc., MSD Inc., Pfizer Japan Inc., Shionogi Inc., and Taisho Toyama Inc. Shunji Takakura has received speaker’s honorarium from Pfizer Japan Inc., Astellas Pharma Inc. Yusuke Tanigawara is a consultant to Meiji Seika Pharma Co., Ltd. Toshimi Kimura has received a speaker’s honorarium from Meiji Seika Pharma.

PY - 2013/6

Y1 - 2013/6

KW - Guideline

KW - MRSA

KW - Therapeutic drug monitoring

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=84879245535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879245535&partnerID=8YFLogxK

U2 - 10.1007/s10156-013-0599-4

DO - 10.1007/s10156-013-0599-4

M3 - Article

C2 - 23673472

AN - SCOPUS:84879245535

VL - 19

SP - 365

EP - 380

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 3

ER -